AInvest Newsletter
Daily stocks & crypto headlines, free to your inbox
Date of Call: November 7, 2025
net income of $10.9 million and diluted earnings per share of $0.74 for Q3 2025, with a GAAP combined ratio of 72.7% and an annualized return on equity of 43%.14% growth in direct written premium, 52% increase in net investment income, and improved retention and rate changes. 4.2% year-over-year and 1.4% sequentially, supported by a 13% average premium increase and expansion efforts. The growth was driven by a reduced quota share, allowing the company to retain a greater share of premiums and underwriting profits, as well as the continued earning-in of previous new business written.
Underwriting and Claim Trends:
4.9 percentage points to 44.1% due to higher claim severity, though claim frequency declined for non-weather water and fire perils. This trend is attributed to a mix shift towards more preferred risk in the Select products, which now represent 54% of policies in force.
Investment Income and Capital Position:
52% to $2.5 million, with a year-to-date increase of 39%, reaching $6.8 million. The increase was due to robust cash generation from operations and the capitalization of attractive new money yields, strengthening the company's capital position.
State Expansion and Market Opportunities:

Overall Tone: Positive
Contradiction Point 1
New States Expansion Impact on Expense Ratio
It involves the expected impact of expanding into new states on the company's expense ratio, which is a key operational metric for evaluating efficiency and profitability.
How will expansion into new states impact your short-term expense ratio? - Robert Farnam(Janney Montgomery Scott LLC)
2025Q3: I don't think it's going to have much of an impact at all. We have built the foundation already. We need to modify the product but our actuarial and claims team is in place. The expenses are immaterial relative to our earned premium growth. - Meryl S. Golden(CEO)
How will expansion into new states affect your short-term expense ratio? - Robert Edward Farnam(Janney Montgomery Scott LLC)
2025Q2: I don't think it's going to have much of an impact at all. We have built the foundation already. We need to modify the product but our actuarial and claims team is in place. The expenses are immaterial relative to our earned premium growth. - Meryl S. Golden(CEO)
Contradiction Point 2
AmGuard Transaction Premium Benefit
It involves the expected premium benefit from the AmGuard transaction, which impacts the company's financial projections and the anticipated integration of the acquired book.
How has the AmGUARD book performed relative to expectations since its launch in early September, excluding profitability, but in terms of policy transfers to Kingstone? - Robert Farnam(Janney Montgomery Scott LLC)
2025Q3: Yes. So it's early on. We started writing business effective September 1st. But so far, it's right within our expectations. So I had indicated that we write between $25 million and $35 million of business over a 3-year period. And we're right on track. - Meryl Golden(CEO)
Why is the AmGuard transaction’s estimated premium benefit lower than expected? - Robert Edward Farnam(Janney Montgomery Scott LLC)
2025Q2: Last quarter, I assumed AmGuard's rate increase would mean producers would proactively move the book, but now I see our rates are higher. Producers and consumers will wait until nonrenewed to join Kingstone, spreading the premium benefit more evenly over 3 years. - Meryl S. Golden(CEO)
Contradiction Point 3
Capital Allocation and Share Buybacks
It involves the company's capital allocation priorities and the consideration of share buybacks, which impact the company's financial strategy and investor expectations.
How are your capital allocation priorities shaped by the dividend reinstatement and future growth? - Gabriel McClure(Private Investor)
2025Q3: We feel we have sufficient capital to fund our growth in the near and midterm. We are in a really good place with no plans for share buybacks. - Meryl Golden(CEO)
How are capital allocation priorities changing with the dividend reinstatement and future growth? - Gabriel McClure(Private Investor)
2025Q2: We feel we have sufficient capital to fund our growth in the near and midterm. We are in a really good place with no plans for share buybacks. - Meryl S. Golden(CEO)
Contradiction Point 4
Expansion into New States and Product Development
It involves plans for geographical expansion and new product development, which are crucial for Kingstone's growth strategy and investor expectations.
Has the new E&S carrier been approved yet? - Robert Farnam
2025Q3: We've received approvals in 11 states so far and expect to enter 3 more states by year-end. It's very likely we'll get approval in Connecticut for the new company, and we'll also start writing business on an E&S basis in Kingstone Insurance Company. - Meryl Golden(CEO)
Are you considering expansion into other jurisdictions? - Q - Unidentified Analyst
2025Q1: Our focus for 2025 is on downstate New York and the AmGUARD transaction. However, this is a good time for Kingstone to consider other geographies. - Meryl Golden(CEO)
Discover what executives don't want to reveal in conference calls

Dec.04 2025

Dec.04 2025

Dec.04 2025

Dec.04 2025

Dec.04 2025
Daily stocks & crypto headlines, free to your inbox
Comments
No comments yet